Mubadala Bio launches adalimumab and ustekinumab treatments in UAE
1 outlet · 0L · 1C · 0R
First reported
1 / 1
We're still gathering coverage of this story.
A neutral account and the side-by-side comparison are written once at least 2 outlets have reported it. Here is the coverage so far.
Left0 articles
No coverage yet.
Centre1 article
Right0 articles
No coverage yet.
- 7 Oct 12:07 First Gulf NewsN UAE pharmaceutical manufacturer Mubadala Bio launches two treatments for immune disorders
Times are when each article was published, or when we first saw it if the outlet gave no time.
Ask about this story
Loading…